Name
Pharmapro OÜ
Registry code
11478963
VAT number
EE101920827
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
31.03.2008 (16)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
68201 - Rental and operating of own or leased real estate
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tanel Kurvits 25.10.1983 (41) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 25.08.2021 | 2020 29.06.2023 | 2021 11.09.2023 | 2022 11.09.2023 | |
|---|---|---|---|---|
| Total Revenue | 37 164 € | 16 587 € | 16 887 € | 18 339 € |
| Net profit (loss) for the period | -4 028 € | -36 338 € | -13 685 € | -46 983 € |
| Profit Margin | -11% | -219% | -81% | -256% |
| Current Assets | 142 719 € | 154 136 € | 153 576 € | 138 535 € |
| Fixed Assets | 173 626 € | 211 513 € | 240 088 € | 229 605 € |
| Total Assets | 316 345 € | 365 649 € | 393 664 € | 368 140 € |
| Current Liabilities | 204 559 € | 290 201 € | 331 901 € | 353 360 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 111 786 € | 75 448 € | 61 763 € | 14 780 € |
| Employees | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 4 384.74 € | 1 424.56 € | 1 609.7 € | 2 |
| 2023 Q4 | 4 779.67 € | 1 294.92 € | 1 467.54 € | 2 |
| 2023 Q3 | 69 425.9 € | 1 637.98 € | 1 467.54 € | 2 |
| 2023 Q2 | 4 924.98 € | 1 294.92 € | 1 467.54 € | 2 |
| 2023 Q1 | 5 075.02 € | 1 300 € | 1 458.52 € | 2 |
| 2022 Q4 | 4 933.55 € | 283.08 € | 1 440.48 € | 2 |
| 2022 Q3 | 3 764.81 € | 1 282.08 € | 1 440.48 € | 2 |
| 2022 Q2 | 4 746.93 € | 1 282.83 € | 1 440.48 € | 2 |
| 2022 Q1 | 4 826.27 € | 1 291.44 € | 1 440.48 € | 2 |
| 2021 Q4 | 4 585.27 € | 1 282.33 € | 1 440.48 € | 2 |
| 2021 Q3 | 4 351.08 € | 1 332.33 € | 1 440.48 € | 2 |
| 2021 Q2 | 3 022.95 € | 1 282.33 € | 1 440.48 € | 2 |
| 2021 Q1 | 300 € | 1 291.69 € | 1 440.48 € | 2 |
| 2020 Q4 | 200 € | 1 088.52 € | 1 178.77 € | 2 |
| 2020 Q3 | - | 1 018.59 € | 1 117.65 € | 2 |
| 2020 Q2 | 14 935.63 € | 3 604.88 € | 1 117.65 € | 2 |
| 2020 Q1 | - | 2 004.88 € | 1 831.34 € | 2 |
